EV/EBITDA
-0.35
0.000.00%
Wed, 12 Mar 2025 21:36:47 GMT
Summary
- As of March 13, 2025, LYRA EV/EBITDA is -0.35, unchanged from the previous trading day.
- Over the past year, LYRA EV/EBITDA has increased by +5.26 (+93.76%).
- LYRA EV/EBITDA is now -160.34% below its all-time high of 0.58.
Performance
LYRA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LYRA EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | -0.6% | -1.1% |
1 m1 month | +5.4% | -5.6% | -10.6% |
3 m3 months | +5.4% | -7.0% | -13.1% |
6 m6 months | -16.7% | +4.2% | -33.0% |
ytdytd | +5.4% | -7.1% | -13.2% |
1 y1 year | +93.8% | -94.2% | -97.2% |
5 y5 years | - | - | - |
LYRA EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.38 | +7.9% | |
3 m | 3-month | -0.34 | -2.9% | -0.40 | +12.5% |
6 m | 6-month | -0.28 | -25.0% | -0.45 | +22.2% |
1 y | 1-year | -0.28 | -25.0% | -5.85 | +94.0% |
3 y | 3-year | 0.58 | -160.3% | -5.85 | +94.0% |
5 y | 5-year | 0.58 | -160.3% | -11.57 | +97.0% |
alltime | all time | 0.58 | -160.3% | -11.57 | +97.0% |
Lyra Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.35(-5.4%) |
2024 | -0.37(-91.9%) |
2023 | -4.58(+249.6%) |
Date | Value |
---|---|
2022 | -1.31(+351.7%) |
2021 | -0.29(-91.5%) |
2020 | -3.40 |
FAQ
- What is Lyra Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lyra Therapeutics?
- What is LYRA EV/EBITDA year-to-date change?
- What is Lyra Therapeutics EV/EBITDA year-on-year change?
What is Lyra Therapeutics EV/EBITDA?
The current EV/EBITDA of LYRA is -0.35
What is the all time high EV/EBITDA for Lyra Therapeutics?
Lyra Therapeutics all-time high EV/EBITDA is 0.58
What is LYRA EV/EBITDA year-to-date change?
Lyra Therapeutics EV/EBITDA has changed by +0.02 (+5.41%) since the beginning of the year
What is Lyra Therapeutics EV/EBITDA year-on-year change?
Over the past year, LYRA EV/EBITDA has changed by +5.26 (+93.76%)